Dyax Corp (DYAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DYAX | CYTK | KRYS | ||
| Company | Dyax Corp | Cytokinetics | Krystal Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.04 | 47.67 | 184.07 | ||
| High | 38.04 | 49.81 | 191.26 | ||
| Low | 38.04 | 47.41 | 182.02 | ||
| Last | 38.04 | 49.10 | 190.40 | ||
| Change | -0.37 | +1.43 | +8.11 | ||
| % Change | -0.96% | +3.00% | +4.45% | ||
| Volume | 400 | 1,640,000 | 222,000 | ||
| 20-Day Average Volume | 3,916,305 | 1,367,540 | 276,775 | ||
| Previous Close | 38.41 | 47.67 | 182.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.87 | 52.83 | 180.53 | ||
| 20-Day Raw Stochastic | 51.85% | 14.11% | 60.52% | ||
| 20-Day Relative Strength | 66.28% | 41.31% | 56.26% | ||
| Weighted Alpha | +77.40 | -16.08 | +38.35 | ||
| Today's Opinion | N/A | 100% Sell | 56% Buy | ||
| Previous Opinion | N/A | 100% Sell | 32% Buy | ||
| Last Month's Opinion | N/A | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.13% since 01/15/16 | -2.23% since 11/15/24 | +11.51% since 11/15/24 | ||
| Low | 38.04 on 01/22/16 | 47.41 on 11/22/24 | 168.88 on 11/18/24 | ||
| High | 38.56 on 01/21/16 | 52.01 on 11/18/24 | 191.26 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +0.93% since 12/22/15 | -10.63% since 10/22/24 | +8.68% since 10/22/24 | ||
| Low | 37.48 on 12/28/15 | 47.41 on 11/22/24 | 163.66 on 11/04/24 | ||
| High | 38.56 on 01/21/16 | 59.39 on 11/11/24 | 207.84 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +42.74% since 10/22/15 | -12.71% since 08/22/24 | -3.60% since 08/22/24 | ||
| Low | 26.53 on 10/23/15 | 47.41 on 11/22/24 | 163.66 on 11/04/24 | ||
| High | 38.56 on 01/21/16 | 59.39 on 11/11/24 | 207.84 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +41.78% since 07/22/15 | -17.10% since 05/22/24 | +12.50% since 05/22/24 | ||
| Low | 17.40 on 09/29/15 | 46.25 on 05/28/24 | 154.50 on 05/29/24 | ||
| High | 38.56 on 01/21/16 | 61.38 on 07/26/24 | 219.34 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,638,660 | 5,794,487 | 5,476,093 | ||
| Shares Outstanding, K | 146,360 | 118,014 | 28,761 | ||
| Annual Sales | 81,720,000 | 7,530,000 | 50,700,000 | ||
| Annual Net Income | -11,880,000 | -526,240,000 | 10,930,000 | ||
| Last Quarter Sales | 24,730,000 | 460,000 | 83,840,000 | ||
| Last Quarter Net Income | -11,700,000 | -160,550,000 | 27,180,000 | ||
| 60-Month Beta | 1.41 | 0.78 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 10/28/15 | -1.36 on 11/06/24 | 0.91 on 11/04/24 | ||
| Latest Earnings Date | 02/23/16 | 11/06/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 86.80 | ||